Molecular Mechanisms Related with Oligometastatic Prostate Cancer-Is It Just a Matter of Numbers?

Area of Science:

• Oncology
• Cancer Metastasis Research

Background:

• The oligometastatic state, a limited metastatic spread, is increasingly understood through molecular frameworks.
• Genetically unstable cells adapt to distant environments, driving metastatic progression.

Purpose of the Study:

• To review the current treatment landscape for oligometastatic cancer.
• To focus on biomarkers for identifying true oligometastatic disease.
• To highlight molecular imaging's impact on staging and discuss targeted therapies for oligometastatic prostate cancer.

Main Methods:

• Narrative review of recent scientific literature.
• Analysis of current biomarkers for oligometastatic disease identification.
• Evaluation of molecular imaging techniques in staging.
• Discussion of genetic and epigenetic treatments.

Main Results:

• Significant advancements in understanding the molecular basis of oligometastatic cancer.
• Established biomarkers aid in identifying true oligometastatic disease.
• Molecular imaging demonstrates impact on stage shift across various scenarios.
• Genetic and epigenetic therapies show promise for oligometastatic prostate cancer.

Conclusions:

• The understanding and management of oligometastatic cancer have advanced significantly.
• Biomarkers and molecular imaging are crucial for accurate diagnosis and staging.
• Targeted therapies offer future directions for treating oligometastatic prostate cancer.